MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Comprehensive motor and non-motor staging system in Parkinson’s disease: Results from a global cross-sectional study

    C. Rodriguez-Blazquez, A. Rizos, K.R. Chaudhuri, P. Martinez-Martin, NILS, EUROPAR and MDS Non-Motor PD Study Groups (Madrid, Spain)

    Objective: To describe a sample of Parkinson's disease (PD) patients by means of a combined, comprehensive, motor and non-motor staging system. Background: PD severity is…
  • 2016 International Congress

    Evaluating the natural history of prodromal PD in the PARS cohort

    D. Jennings, A. Siderowf, M. Stern, K. Marek, PARS Study Investigators (New Haven, CT, USA)

    Objective: An objective of the Parkinson Associated Risk Syndrome (PARS) study is to identify a cohort 'at risk' for Parkinson's disease (PD) using sequential olfactory…
  • 2016 International Congress

    Application and correlates of the PSP quality of life scale

    L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

    Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating…
  • 2016 International Congress

    Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

    P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: To characterize the clinical features and prevalence of patients with progressive supranuclear palsy (PSP) in the recently implemented longitudinal Parkinson's cohort (HELP-PD). Background: PSP…
  • 2016 International Congress

    Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

    I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)

    Objective: To study and report the frequency of movement disorders in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Background: CADASIL is the main…
  • 2016 International Congress

    Emotion processing in Parkinson’s disease – Possible link between inability to decode complex emotional stimuli and impairment of executive functions

    E. Klimiec, K. Kowalska, P. Pasinska, A. Szyper, T. Dziedzic, A. Slowik, A. Klimkowicz-Mrowiec (Krakow, Poland)

    Objective: To compare: (1) emotional decoding abilities and (2) executive functions between Parkinson's disease patients (PD) and healthy controls. Background: Emotion decoding abilities are important…
  • 2016 International Congress

    Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease

    S.J. Chung, J.J. Lee, J.H. Ham, P.H. Lee, Y.H. Sohn (Seoul, Korea)

    Objective: We performed this study to investigate whether dopamine depletion in the ventral striatum contributes to apathy in PD. Background: Apathy is a common, disabling…
  • 2016 International Congress

    Parkinsonism risk factors in Salt Lake City, Utah

    D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

    Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…
  • 2016 International Congress

    Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

    M. Salari (Isfahan, Islamic Republic of Iran)

    Objective: To evaluated demographic and clinical characteristic feature of patients with Parkinson's disease in Isfahan city in Iran. Background: Parkinson's disease (PD) is one of…
  • 2016 International Congress

    Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort

    P. Mahlknecht, A. Gasperi, P. Willeit, S. Kiechl, H. Stockner, J. Willeit, G. Rungger, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To quantify the prevalence of prodromal phase of Parkinson's disease (PD) defined per 2015 MDS research criteria and their potential to predict incident clinically…
  • « Previous Page
  • 1
  • …
  • 399
  • 400
  • 401
  • 402
  • 403
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley